These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 12603849)
1. Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies. Leyendeckers H; Tasanen K; Bruckner-Tuderman L; Zillikens D; Sitaru C; Schmitz J; Hunzelmann N J Invest Dermatol; 2003 Mar; 120(3):372-8. PubMed ID: 12603849 [TBL] [Abstract][Full Text] [Related]
2. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model. Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714 [TBL] [Abstract][Full Text] [Related]
4. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180. Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678 [TBL] [Abstract][Full Text] [Related]
5. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301 [TBL] [Abstract][Full Text] [Related]
6. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. Hofmann S; Thoma-Uszynski S; Hunziker T; Bernard P; Koebnick C; Stauber A; Schuler G; Borradori L; Hertl M J Invest Dermatol; 2002 Nov; 119(5):1065-73. PubMed ID: 12445194 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629 [TBL] [Abstract][Full Text] [Related]
8. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. Lin MS; Fu CL; Giudice GJ; Olague-Marchan M; Lazaro AM; Stastny P; Diaz LA J Invest Dermatol; 2000 Dec; 115(6):955-61. PubMed ID: 11121125 [TBL] [Abstract][Full Text] [Related]
9. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393 [TBL] [Abstract][Full Text] [Related]
11. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799 [TBL] [Abstract][Full Text] [Related]
12. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid. Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201 [TBL] [Abstract][Full Text] [Related]
13. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132 [TBL] [Abstract][Full Text] [Related]
14. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. Fairley JA; Fu CL; Giudice GJ J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622 [TBL] [Abstract][Full Text] [Related]
16. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407 [TBL] [Abstract][Full Text] [Related]
17. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model. Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071 [TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259 [TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain. Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788 [TBL] [Abstract][Full Text] [Related]
20. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid. Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]